U.S. Court of Appeals for the Federal Circuit, 2020

Provepharm Inc. v. Wista Laboratories Ltd.

Provepharm Inc. v. Wista Laboratories Ltd.
U.S. Court of Appeals for the Federal Circuit · Decided December 14, 2020

Provepharm Inc. v. Wista Laboratories Ltd.

Opinion

Case: 19-2372 Document: 87 Page: 1 Filed: 12/14/2020

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ PROVEPHARM INC., Appellant v. WISTA LABORATORIES LTD., Appellee ANDREI IANCU, UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK OFFICE, Intervenor ______________________ 2019-2372, 2019-2373 ______________________ Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2018- 00182, IPR2018-00323. ______________________ JUDGMENT ______________________ CHRISTOPHER RICCIUTI, Oblon, McClelland, Maier and Neustadt, LLP, Alexandria, VA, argued for appellant. Also represented by TIA FENTON, GRACE KIM.

Case: 19-2372 Document: 87 Page: 2 Filed: 12/14/2020

NATHAN R. SPEED, Wolf, Greenfield & Sacks, PC, Bos- ton, MA, argued for appellee. Also represented by RICHARD GIUNTA, ERIC J. RUTT, EDWARD R. GATES.

PETER JOHN SAWERT, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA, for intervenor. Also represented by THOMAS W. KRAUSE, FARHEENA YASMEEN RASHEED. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (DYK, MOORE, and O’MALLEY, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

December 14, 2020 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.